Company Directory - IQVIA Inc.
Company Details - IQVIA Inc.
IQVIA Inc.
WebsiteIQVIA is a global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry.
CCI Score
CCI Score: IQVIA Inc.
-44.70
0.02%
Latest Event
IQVIA Political Influence Profile (2024-2025)
IQVIA’s significant political contributions and lobbying expenditures, combined with a concerning revolving door among its lobbyists, raise alarms about its influence on democratic institutions and potential support for authoritarian policies.
Take Action
So what can you do? It's time to make tough choices. Where will you cast your vote?
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
TOADIE
IQVIA Inc. is currently rated as a Toadie.
Latest Events
- FEB192025
IQVIA’s significant political contributions and lobbying expenditures, combined with a concerning revolving door among its lobbyists, raise alarms about its influence on democratic institutions and potential support for authoritarian policies.
-70
Political Contributions and Lobbying Efforts
March 26
IQVIA contributed $192,457 and spent $680,000 on lobbying in the 2024 cycle, indicating a heavy investment in shaping political outcomes that may favor authoritarian policies. The financial influence and extensive lobbying efforts raise significant concerns about corporate complicity in eroding democratic processes.
-50
Executive Political Engagement
March 26
The revolving door pattern, with a high proportion of IQVIA lobbyists having previously held government positions, indicates potential conflicts of interest and a compromised democratic process through blurred lines between public service and private influence.
- JAN202025
IQVIA Inc. reached a conciliation agreement with the U.S. Department of Labor’s OFCCP to pay $550,000 in back wages and interest to resolve allegations of gender- and race-based discrimination at its Parsippany, New Jersey facility.
-75
Labor Relations and Human Rights Practices
March 26
The settlement reveals serious failures in IQVIA's labor practices, specifically in ensuring non-discriminatory hiring processes for female and Black applicants. This case highlights systemic biases and a breach of ethical responsibilities in business practices, warranting a significantly negative score in labor relations and human rights practices.
- DEC312024
IQVIA spent $680,000 on lobbying in 2024, raising concerns about its potential influence over policy-making and democratic accountability.
-40
Political Contributions and Lobbying Efforts
March 26
According to OpenSecrets, IQVIA spent $680,000 on lobbying in 2024. This substantial lobbying expenditure is considered indicative of efforts to shape political outcomes in ways that could support authoritarian practices, undermining public accountability and democratic processes.
- JUN302024
IQVIA disclosed $60,000 in lobbying expenditures in Q2 2024, targeting government contracting issues, data privacy proposals, and labor appropriations. This disclosure raises concerns about the company using its political influence to shape policies in ways that may undermine democratic oversight and enable authoritarian practices.
-40
Political Contributions and Lobbying Efforts
March 26
IQVIA's disclosed $60,000 lobbying spend in Q2 2024 on issues like government contracting, data privacy, and labor appropriations reflects a deliberate engagement in political lobbying. From a left-leaning anti-fascist perspective, even a moderate amount of corporate lobbying is problematic because it signals an attempt to influence policy in favor of corporate interests, potentially undermining democratic processes and favoring authoritarian tendencies.
Lobbying Update: $60,000 of IQVIA HOLDINGS INC. lobbying was just disclosed
- DEC292023
On December 29, 2023, the U.S. District Court granted the FTC’s request for a preliminary injunction to block IQVIA’s proposed acquisition of Propel Media. The move came amid concerns that the merger would have consolidated market power in healthcare advertising, potentially leading to anticompetitive outcomes, higher costs, and reduced consumer choice.
-35
Business Practices and Ethical Responsibility
March 26
IQVIA’s attempted acquisition of Propel Media raises significant antitrust concerns. The move could have led to an undue consolidation of market power in the healthcare sector, undermining ethical business practices by potentially driving up costs and limiting competition. Such anticompetitive actions are seen as detrimental in the context of corporate responsibility and market fairness.
Statement on FTC Win Securing Temporary Block of IQVIA’s Acquisition of Propel Media
-40
Economic and Structural Influence
March 26
The attempted merger would have significantly increased IQVIA’s structural influence by potentially creating a dominant market position in healthcare advertising. This concentration of economic power not only threatens fair competition but also risks shifting industry dynamics in ways that could support monopolistic practices and indirectly affect democratic market oversight.
Statement on FTC Win Securing Temporary Block of IQVIA’s Acquisition of Propel Media
- JUL172023
On July 17, 2023, the FTC filed a lawsuit to block IQVIA's proposed acquisition of Propel Media Inc., alleging that the deal would give the company a market-leading position in programmatic advertising for health care products. This has raised concerns about potential media consolidation and undue market influence that could distort public discourse and democratic accountability.
-30
Technology and Services Impact
March 26
The acquisition would enhance IQVIA’s technological capabilities in programmatic advertising, potentially leading to consolidation of media influence. Such concentration may enable the company to manipulate health care product narratives, thereby subtly shaping public opinion and undermining democratic dialogue.
-50
Economic and Structural Influence
March 26
The proposed acquisition could position IQVIA as a dominant player in the market, fostering an imbalance in economic and structural influence. This concentration of market power may facilitate regulatory capture and weaken checks on the firm’s practices, which is concerning from an anti-fascism and accountability perspective.
- APR182023
The article highlights IQVIA's political contributions, which raise concerns about the company's potential influence on political processes. This activity is seen through a left-leaning lens as a worrisome signal of corporate complicity in supporting authoritarian agendas by potentially funding far-right or authoritarian-leaning political entities.
-40
Political Contributions and Lobbying Efforts
March 26
IQVIA's political contributions, as documented in the article, suggest active engagement in political funding that may advocate for or support authoritarian policies. From a politically left-leaning, anti-fascist perspective, such contributions are problematic as they could help bolster political entities that undermine democratic norms. Although details on which specific political groups benefited are sparse, the act of making political contributions itself raises important questions about corporate complicity in the erosion of democratic accountability.
- APR252022
IQVIA Inc. has agreed to pay $550,000 in back wages and interest to settle a bias lawsuit alleging discriminatory hiring practices against female and Black applicants at its Parsippany, N.J. facility, revealing significant issues in its labor relations and human rights practices.
-50
Labor Relations and Human Rights Practices
March 26
The bias lawsuit settlement exposes IQVIA's failure to provide equal employment opportunities, as evidenced by discriminatory hiring practices against female and Black applicants. Such practices undermine fair labor standards and contribute to systemic inequities, reflecting negatively on the company's labor relations and human rights practices.
Health-Care Company IQVIA to Pay $550,000 to Settle Bias Suit
- APR252022
IQVIA Inc. agreed to a $550,000 settlement to compensate 984 female and Black applicants following a U.S. Department of Labor investigation that uncovered discriminatory hiring practices at its Parsippany, New Jersey facility. The incident highlights lapses in labor rights and human resources policies, marking a setback in ethical labor practices.
-60
Labor Relations and Human Rights Practices
March 26
The settlement stemmed from an OFCCP investigation that found IQVIA Inc. engaged in discriminatory hiring practices against female and Black applicants. This failure to uphold fair labor practices and equal opportunity standards significantly undermines worker rights, contributing negatively to the company’s overall adherence to ethical business practices.
- APR252022
IQVIA Inc. has agreed to pay $550K in back wages and interest following an OFCCP investigation. The penalty arises from discriminatory hiring practices against female and Black applicants, indicating significant shortcomings in upholding labor rights and ethical employment standards.
-80
Labor Relations and Human Rights Practices
March 26
IQVIA Inc. was found to have engaged in discriminatory hiring practices that adversely affected 984 qualified female and Black applicants, violating labor rights and federal non-discrimination laws. This action not only harms the affected individuals but also contributes to a broader pattern of systemic inequality, undermining ethical labor practices and indirectly supporting exclusionary structures associated with authoritarianism.
Alternatives

Corporation
66.75

Corporation
-4.30
Framingham, United States
40.16
London, United Kingdom
18.61

Stamford, United States
14.63
Dublin, Ireland
-16.41
Corporation
71.61
Corporation
69.66
Corporation
26.00

Corporation
-32.15
Industries
- 541511
- Custom Computer Programming Services
- 541612
- Human Resources Consulting Services
- 541618
- Other Management Consulting Services
- 541690
- Other Scientific and Technical Consulting Services
- 541712
- Research and Development in the Physical, Engineering, and Life Sciences (Biotechnology)
- 541711
- Research and Development in Biotechnology